Authors:
Gülfem Terek Ece Bozyaka Education and Research Hospital, Department of Medical Microbiology, İzmir, Türkiye

Search for other papers by Gülfem Terek Ece in
Current site
Google Scholar
PubMed
Close
,
Doğukan Pira Faculty of Medicine, İzmir University of Economics, İzmir, Türkiye

Search for other papers by Doğukan Pira in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-0386-2920
, and
Gökçe Lara Bodur Faculty of Medicine, İzmir University of Economics, İzmir, Türkiye

Search for other papers by Gökçe Lara Bodur in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract

Human Papillomavirus (HPV) is a primarily sexually transmitted human pathogen linked with the formation of anogenital warts and several types of cancer including cervical cancer, oropharyngeal cancer, penile cancer, and anal cancer. HPV genotypes are divided into high-risk and low-risk in accordance with their potential for carcinogenesis. The most notable high-risk genotypes are HPV-16 and HPV-18. In this study we report on the PCR analysis results of the cervical smear results of 328 females, and 50 males who have presented to a tertiary care university hospital in the port city of İzmir, Türkiye between August 2019 and August 2022. HPV-DNA positivity percentage was determined as 25.3% (96/378). 5 of 378 patients were HPV-18 positive (age range 31–80) whereas 27 patients were HPV-16 positive (age range 29–66). 64 patients were positive for other high-risk HPV types (age range 27–56). The positivity for HPV-16, HPV-18 and other high-risk HPV types were determined as 7.14%, 1.3% and 16.9% respectively. Our results demonstrate a 25.3% (96/378) positivity among tested patients moreover, out of 96 positive cases at least 32 are vaccine preventable. This study indicates the need for higher coverage of HPV vaccination in Western Türkiye.

  • 1.

    Peker BO, Müderris T, Gül Yurtsever S, Kaya S. Servikal fırça örneklerinde insan papilloma virüs prevalansı ve genotip dağılımı; üç yıllık analiz [Human papillomavirus prevalence and genotype distribution in Servical swab samples: outcomes of a three-year analysis]. Turk Mikrobiyol Cemiy Derg 2022; 52(3): 168174. Turkish.

    • Search Google Scholar
    • Export Citation
  • 2.

    Vos RA, Pasmans H, Tymchenko L, Janga-Jansen A, Baboe-Kalpoe S, Hulshof K, et al. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands. Vaccine 2020; 38(13): 28162826. Available from: https://doi.org/10.1016/j.vaccine.2020.02.017.

    • Search Google Scholar
    • Export Citation
  • 3.

    Zhang J, Zhang D, Yang Z, Wang X, Wang D. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China. BMC Cancer 2020; 20(1): 443. Published 2020 May 19. https://doi.org/10.1186/s12885-020-06935-w.

    • Search Google Scholar
    • Export Citation
  • 4.

    World Health Organization. Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancerPublished Feb 22, 2022. Accessed Oct 24, 2022.

    • Search Google Scholar
    • Export Citation
  • 5.

    Choi YJ, Park JS. Clinical significance of human papillomavirus genotyping. J Gynecol Oncol 2016; 27(2): e21. https://doi.org/10.3802/jgo.2016.27.e21.

    • Search Google Scholar
    • Export Citation
  • 6.

    Öztürker O, Sönmez G. Endometrium ve Serviks Kanserlerinde Görüntüleme [Imaging in endometrial and cervical cancer]. Trd Sem 2015; 3: 111. https://doi.org/10.5152/trs.2015.158Accessed Oct 23, 2022. Turkish.

    • Search Google Scholar
    • Export Citation
  • 7.

    Usubütün A, Alemany L, Küçükali T, Ayhan A, Yüce K, Sanjosé Silvia, et al. Human papillomavirus types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol 2009; 28(6): 541548. Available from: https://doi.org/10.1097/PGP.0b013e3181aaba0d.

    • Search Google Scholar
    • Export Citation
  • 8.

    Hancer VS, Buyukdogan M, Bylykbashi I, Oksuz B, Acar M. Prevalence of human papilloma virus types in Turkish and Albanian women. J Cytol 2018; 35(4): 252254. https://doi.org/10.4103/JOC.JOC_162_17.

    • Search Google Scholar
    • Export Citation
  • 9.

    Campari C, Fedato C, Iossa A, Petrelli A, Zorzi M, Anghinoni E, et al. Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results. Eur J Cancer Prev 2016; 25(4): 321328. JSTOR, https://www.jstor.org/stable/48504705. Accessed 25 Oct. 2022.

    • Search Google Scholar
    • Export Citation
  • 10.

    Alan M, Oruç MA, Yılmaz N, Aytaç H, Sanci M, Alan Y. Evaluation of HPV incidence and cervical smear results in Syrian refugees. Ankara Med J 2020; 20(1): 110.

    • Search Google Scholar
    • Export Citation
  • 11.

    Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. ICO/IARC information Centre on HPV and cancer (HPV Information Centre). Human papillomavirus and related diseases in the world. Summary report. https://hpvcentre.net/statistics/reports/XWX.pdf. Published Oct 22, 2021. Accesssed Oct 24, 2022.

    • Search Google Scholar
    • Export Citation
  • 12.

    Duran , Alev E, Sayıner A. Determination of human papilloma viruses DNA and genotypes in genital samples with PCR. J Clin Anal Med 2017; 8: 302306. Available from: https://doi.org/10.4328/JCAM.4881.

    • Search Google Scholar
    • Export Citation
  • 13.

    Sahin HG, Kolusari A, Guducuoglu H. Prevalence of high risk human papillomavirus (HPV) infection and abnormal cervical cytology and knowledge about HPV vaccine in Eastern Turkey. Eur J Gynaecol Oncol 2017; 38(2): 241244.

    • Search Google Scholar
    • Export Citation
  • 14.

    Özmen E, Altoparlak Ü, Uyanık MH, Gülen A. Servikal örneklerde yüksek riskli human papillomavirüs genotiplerinin dağılımı ve prevalansı [The distribution and prevelance of high-risk Human Papillomavirus genotypes in cervical samples]. FLORA 2020; 25(3): 325331. Turkish.

    • Search Google Scholar
    • Export Citation
  • 15.

    Kan Ö, Görkem Ü, Barış A, Koçak Ö, Toğrul C, Yıldırım E. Evaluation of the frequency of Human Papillomavirus (HPV) in women admitted to cancer early diagnosis and screening training centers (KETEM) and analysis of HPV genotypes. Türk Hijyen ve Deneysel Biyoloji Dergisi 2019; 76(2): 163168.

    • Search Google Scholar
    • Export Citation
  • 16.

    Kazancı F, Koçak A, Colak M, Erdem Ö, Bozdayi G. HPV tip 66’yı Olası yüksek riskli Grupta Değerlendirmeli miyiz? Ankara Gazi Üniversitesi’ndeki HPV tip 66’nın prevalansı, Klinik ve histopatolojik Değerlendirmesi [Should we evaluate HPV-66 as a high-risk group member? A prevalence, clinical and histopathological evaluation in Ankara Gazi university]. Gazi Medical Journal 2021; 32: 98103 Turkish.

    • Search Google Scholar
    • Export Citation
  • 17.

    Alacam S, Bakir A. Human papillomavirus prevalence and genotype distribution in cervical swab samples in Istanbul, Turkey. J Infect Dev Ctries 2021; 15(8): 11901196. https://doi.org/10.3855/jidc.14663.

    • Search Google Scholar
    • Export Citation
  • 18.

    Argyri E, Tsimplaki E, Papatheodorou D, Daskalopoulou D, Panotopoulou E. Recent trends in HPV infection and type distribution in Greece. Anticancer Res 2018; 38(5): 30793084. https://doi.org/10.21873/anticanres.12565.

    • Search Google Scholar
    • Export Citation
  • 19.

    Fappani C, Bianchi S, Panatto D, Petrelli F, Colzani D, Scuri S, et al. HPV type-specific prevalence a decade after the implementation of the vaccination program: results from a Pilot study. Vaccines 2021; 9: 336. Available from: https://doi.org/10.3390/vaccines9040336.

    • Search Google Scholar
    • Export Citation
  • 20.

    Salavatiha Z, Farahmand M, Shoja Z, Jalilvand S. A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer. J Med Virol 2021; 93(8): 46474658. https://doi.org/10.1002/jmv.26928.

    • Search Google Scholar
    • Export Citation
  • 21.

    Al Moustafa AE, Ghabreau L, Akil N, Rastam S, Alachkar A, Yasmeen A. High-risk HPVs and human carcinomas in the Syrian population. Front Oncol 2014; 4: 68. Published 2014 Apr 2. https://doi.org/10.3389/fonc.2014.00068.

    • Search Google Scholar
    • Export Citation
  • 22.

    Maver PJ, Poljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect 2020; 26(5): 579583.

    • Search Google Scholar
    • Export Citation
  • 23.

    Arbyn M, Simon M, Peeters E, Xu L, Meijer CJLM, Berkhof J, et al. 2020 List of human papillomavirus assays suitable for primary cervical cancer screening. Clin Microbiol Infect 2021; 27(8): 10831095.

    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • CABELLS Journalytics
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded

2023  
Web of Science  
Journal Impact Factor 1.3
Rank by Impact Factor Q4 (Immunology)
Journal Citation Indicator 0.31
Scopus  
CiteScore 2.3
CiteScore rank Q3 (Infectious Diseases)
SNIP 0.389
Scimago  
SJR index 0.308
SJR Q rank Q3

Acta Microbiologica et Immunologica Hungarica
Publication Model Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article (only for OA publications)
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2025 Online subsscription: 772 EUR / 848 USD
Print + online subscription: 860 EUR / 944 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2024 64 1 1
Jun 2024 75 1 2
Jul 2024 49 0 0
Aug 2024 55 0 0
Sep 2024 62 0 0
Oct 2024 157 1 1
Nov 2024 39 0 0